Oleg Iartchouk

Novartis (Switzerland) — Switzerland

Computer Science · Physical Sciences

13h-index2.4kcitations53works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Computational Drug Discovery Methods(16), Lung Cancer Treatments and Mutations(4), RNA and protein synthesis mechanisms(4), CRISPR and Genetic Engineering(4), Cancer Genomics and Diagnostics(4)

Publications53 total

Supplemental Figure S5 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
2025Open Access
Supplemental Tables 1 - 12 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
2025Open Access
Supplemental Figure S3 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
2025Open Access
Supplemental Figure S2 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
2025Open Access
Supplemental Figure S8 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
2025Open Access
Supplemental Figure S6 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
2025Open Access
Supplemental Figure S1 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
2025Open Access
Supplemental Figure S7 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
2025Open Access
Supplemental Figure S4 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
2025Open Access
Supplemental Figure and Table Legends from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
2025Open Access
Genomic crosstalk between carbachol, a muscarinic receptor agonist, and the long-acting β2-adrenoceptor agonist, indacaterol, in human airway epithelial cells
Journal of Pharmacology and Experimental Therapeutics·2025
Supplemental Tables 1 - 12 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
2023Open Access
Supplemental Figure S5 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
2023Open Access
Supplemental Figure S8 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
2023Open Access
Supplemental Figure S5 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
2023Open Access
Supplemental Figure S6 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
2023Open Access
Supplemental Figure S4 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
2023Open Access
Supplemental Figure S3 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
2023Open Access
Supplemental Figure S1 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
2023Open Access
Supplemental Figure S8 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
2023Open Access
page 1 of 3Next →

Frequent Co-authors

David A. Ruddy(32), Julie Chen(32), Joel P. Wagner(32), Jeffrey A. Engelman(32), Michelle Piquet(31), Markus Riester(31), Javier Estrada(31), Leandra Mansur(31), Tyler Burks(31), Jennifer L. Cotton(30), Vivek Sagar(30), John Alford(30), Youngchul Song(30), Xiaoyan Li(30), Matthew T. DiMare(30), Katja Schumacher(30), Gaylor Boulay(30), Kathleen Sprouffske(30), Lin Fan(30), Hyo‐eun C. Bhang(30)